Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform ...
As previously reported yesterday afternoon, Canaccord upgraded Vertex Pharmaceuticals (VRTX) to Hold from Sell with a price target of $424, up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results